FULL YEAR AND FOURTH QUARTER 2025 EARNINGS PRESENTATION February 26, 2026 Use of non-GAAP financial measures: This presentation includes certain non‐GAAP financial measures intended to supplement, not substitute for, comparable GAAP measures. Reconciliations of non‐GAAP financial measures to GAAP financial measures are provided within the Appendix to this presentation. Investors are urged to consider carefully the comparable GAAP measures and the reconciliations to those measures provided. The company does ...

INVESTOR PRESENTATION Q4 2025 Speakers: McKeel Hagerty, Chief Executive Officer and Chairman Patrick McClymont, Chief Financial Officer Forward Looking Statements / Non-GAAP Financial Measures This presentation contains statements that constitute "forward- looking statements" within the meaning of the federal securities laws. All statements we provide, other than statements of historical fact, are forward-looking statements, including those regarding our future operating results and financial position, our ...

4Q 2025 Investor presentation Presented by NASDAQ: PAYO INVESTOR.PAYONEER.COM Presented by Date February 26, 2026 Disclaimers This presentation does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any security. You should not construe the contents of this presentation as legal, tax, accounting or investment advice or a recommendation. Forward-Looking Statements Certain statements in this presentation may be considered "forward-looking statements" within th ...

Full Year and Fourth Quarter 2025 Earnings Call February 26, 2026 FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements that reflect our current views with respect to, among other things, our 2026 outlook, our operations and our financial performance. These forward-looking statements are included throughout this presentation and relate to matters such as our industry, business strategy, goals and expectations concerning our market position, future operations, strategic priorities ...

– Generated Quarterly Net Revenues of $205.4 Million, Up 13% Year-over-Year, and Record Full-Year Net Revenues of $780.6 Million, Up 24% Year-over-Year – – Generated Record Quarterly and Full-Year Jornay PM® Net Revenue of $45.9 Million and $148.9 Million, Up 57% and 48%, Respectively, Year-over-Year – – Generated Quarterly Pain Portfolio Net Revenues of $159.6 Million, Up 5% Year-over-Year, and Record Full-Year Pain Portfolio Net Revenues $631.7 Million, Up 6% Year-over-Year – – Ended 2025 with Cash, Cash ...

—Full year 2025 ORLADEYO® net revenue of $601.8 million (+38% y-o-y; +43% y-o-y excluding European ORLADEYO revenue following the sale of the European ORLADEYO business to Neopharmed Gentili S.p.A. on October 1, 2025)— —Record GAAP and non-GAAP operating profit for full year 2025— —Maintained full year 2026 ORLADEYO revenue guidance between $625 and $645 million— —Received FDA approval for ORLADEYO oral pellets for patients with HAE Aged 2 to <12 Years— Non-GAAP figures are provided with adjustments, as app ...

"In 2025 we successfully completed Phase I of the Indivior Action Agenda – Generate Momentum," said Joe Ciaffoni, Chief Executive Officer. "We sharpened our focus on our highest growth opportunity, U.S. SUBLOCADE, established our "go-forward" operating model and strengthened our financial profile. We are now executing Phase II of the Indivior Action Agenda – Accelerate, which includes accelerating SUBLOCADE throughout 2026 and immediately accelerating adjusted EBITDA and cash flow at a faster rate. We expec ...

Revenue and Adjusted EBITDA results delivered in line with stated full-year targets Full ‑ year cost savings exceeded previously communicated targets Highlights: DURHAM, N.C., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the "Company"), a leading global contract research organization (CRO), today reported financial results for the fourth quarter and full year ended December 31, 2025. The goodwill impairments occurred during the first half of 2025 and primarily resulted from declines in the Comp ...

Delivers Outstanding Fourth Quarter Results and Issues Full Year 2026 Guidance Fourth Quarter 2025 Highlights Full Year 2025 Highlights Full Year 2026 Guidance Introducing full year 2026 guidance ranges for Revenues of $1,625 million to $1,700 million, Adjusted EBITDA of $460 million to $485 million, Adjusted Net Income of $200 million to $220 million, and Adjusted Diluted Earnings Per Share of $1.15 to $1.25 ATLANTA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a global softw ...

StandardAero (NYSE:SARO) Q4 2025 Earnings call February 25, 2026 05:00 PM ET Company ParticipantsAlex Trapp - Chief Strategy OfficerDan Satterfield - CFOKristine Liwag - Executive Director and Head of Aerospace & Defense Equity ResearchRama Bondada - Senior Vice President of Investor RelationsRussell Ford - Chairman and CEOSheila Kahyaoglu - Managing Director in Equity ResearchConference Call ParticipantsDoug Harned - Managing Director and Senior AnalystGavin Parsons - Equity AnalystKrista Friesen - Equity ...